CPAP therapy lowers heart risks in high-risk sleep apnea patients but may raise them in low-risk individuals, highlighting ...

Everhope Oncology takes the anxiety out of cancer treatment — with zero wait time, 2X faster service, pre-booked diagnostics, and personalised concierge-led assistance.

The Smart Healthcare Pavilion at Taiwan Expo USA 2025 will take place at the Kay Bailey Hutchison Convention Center in Dallas, Texas, from August 14 to 16. Featuring two world-leading hospitals and ...

A revolutionary theory that traces bipolar disorder to our Neanderthal ancestors is the subject of a provocative new book by psychologist and researcher Julia A.

Today, the Medical College of Wisconsin (MCW) hosted a ribbon cutting ceremony to celebrate the grand opening of its new cancer research facility. The Center for Cancer Discovery (CCD) is a modern ...

Bracco Imaging, a global leader in diagnostic imaging, today announced that its ultrasound contrast agent SonoVue® has been approved by the China's National Medical Products Administration (NMPA) for ...

With the first day of school right around the corner, many children – and their parents – are experiencing a mix of excitement and worry. Experts remind families that not all anxiety is bad and that ...

Legionnaires' disease lawyer Jory Lange and prominent Manhattan attorney Scott Harford have been retained to investigate an outbreak of Legionnaires' disease in Central Harlem that ...

Novo Nordisk today announced the filing of 14 new lawsuits to safeguard patients from unsafe and unapproved compounded drugs claiming to contain "semaglutide." The defendants named in these lawsuits ...

A groundbreaking multicenter clinical study published on July 30 in JAMA Surgery confirms the powerful diagnostic performance of the Destinex assay, a novel liquid biopsy that serves as the foundation ...

With students across the country preparing to head back to school in the weeks ahead, today the American Lung Association, in collaboration with Lakes International Language Academy (LILA), a charter ...

U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of two oral formulations of ASC30, a once-daily tablet, in 125 participants with obesity ...